Hair loss prevention for chemotherapy patients.
Patented and cleared by the FDA in 2021, Amma is the world’s first patient administered scalp-cooling solution. Based on current reimbursement available, Cooler Heads provides the Amma platform directly to infusion centers, giving patients access to this scalp cooling solution throughout their chemotherapy regimen. Our objective is to make this option available at every infusion center across the country.
Cooler Heads transforms life for people diagnosed with cancer by giving them more control over how they experience the side effects of treatment. Cooler Heads’ debut product is Amma, an affordable and transportable scalp-cooling system that democratizes the innovative therapy. Amma™ gives people with cancer a choice in whether they lose their hair during chemotherapy. This impacts more than how they look; it impacts their entire sense of self, and it can improve their mental health and their recovery.
By partnering directly with Cooler Heads, healthcare providers can now provide the Amma technology straight to the patients they serve. For patients, this means having easier access to scalp cooling from those intimately invested in your day-to-day care.
“Cancer patients undergoing chemotherapy are dealing with the hardest challenge one can face; keeping their hair is critical to their mental health, their sense of self, and their recovery process.”
Kate Dilligan, CEO
Portable within infusion center
Easy to use
How it works
Amma™ is designed to be portable and wholly self-administered by the patient. Due to the mobility of the unit, the patient can leave the infusion chair to complete their scalp cooling therapy anywhere in the infusion center.
Amma device is available at infusion center*
Receive capping components from infusion center
Watch the self-demo tutorial with Amma trainer
Begin scalp cooling treatment at infusion center
*Amma is currently available at participating infusion center locations and growing daily.
Executive Leadership Team
Founder & CEO
Head of Engineering
Global VP Sales & Marketing
Cooler Heads was founded in 2018 by Kate Dilligan, a tech entrepreneur and breast cancer survivor, to protect the dignity, privacy, and identity of cancer patients. After Kate was diagnosed with breast cancer, she spent $8,000 on traditional cold cap therapy. After talking with countless cancer patients frustrated by the high cost, poor fit, and difficulty of use of existing methods, Kate was determined to engineer a better way.
Cooler Heads’ Amma is the only portable, FDA-cleared scalp cooling unit available. With Amma, facilities across the country can now provide this treatment to eligible patients without compromising space and chair time.
Recent Press & Podcasts
Follow Us on Social Media